Logo image of BIM.PA

BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:BIM - FR0013280286 - Common Stock

104.8 EUR
+0.6 (+0.58%)
Last: 12/5/2025, 5:36:15 PM
Fundamental Rating

6

BIM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. While BIM has a great health rating, its profitability is only average at the moment. BIM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BIM had positive earnings in the past year.
BIM had a positive operating cash flow in the past year.
In the past 5 years BIM has always been profitable.
In the past 5 years BIM always reported a positive cash flow from operatings.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

BIM's Return On Assets of 7.04% is fine compared to the rest of the industry. BIM outperforms 76.92% of its industry peers.
BIM has a Return On Equity of 9.61%. This is comparable to the rest of the industry: BIM outperforms 60.00% of its industry peers.
BIM has a Return On Invested Capital of 8.55%. This is in the better half of the industry: BIM outperforms 73.85% of its industry peers.
BIM had an Average Return On Invested Capital over the past 3 years of 10.05%. This is in line with the industry average of 9.72%.
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROIC 8.55%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BIM has a Profit Margin of 9.17%. This is in the better half of the industry: BIM outperforms 61.54% of its industry peers.
In the last couple of years the Profit Margin of BIM has remained more or less at the same level.
BIM's Operating Margin of 12.37% is in line compared to the rest of the industry. BIM outperforms 53.85% of its industry peers.
BIM's Operating Margin has improved in the last couple of years.
BIM has a Gross Margin (56.27%) which is in line with its industry peers.
BIM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.37%
PM (TTM) 9.17%
GM 56.27%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BIM is creating some value.
The number of shares outstanding for BIM remains at a similar level compared to 1 year ago.
BIM has less shares outstanding than it did 5 years ago.
BIM has a better debt/assets ratio than last year.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

BIM has an Altman-Z score of 6.56. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BIM (6.56) is better than 90.77% of its industry peers.
The Debt to FCF ratio of BIM is 1.15, which is an excellent value as it means it would take BIM, only 1.15 years of fcf income to pay off all of its debts.
BIM has a Debt to FCF ratio of 1.15. This is amongst the best in the industry. BIM outperforms 87.69% of its industry peers.
BIM has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BIM (0.09) is better than 81.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Altman-Z 6.56
ROIC/WACC1.08
WACC7.91%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

BIM has a Current Ratio of 2.27. This indicates that BIM is financially healthy and has no problem in meeting its short term obligations.
BIM has a Current ratio of 2.27. This is in the better half of the industry: BIM outperforms 61.54% of its industry peers.
A Quick Ratio of 1.30 indicates that BIM should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.30, BIM perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.3
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

The earnings per share for BIM have decreased by -8.23% in the last year.
BIM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.91% yearly.
Looking at the last year, BIM shows a quite strong growth in Revenue. The Revenue has grown by 8.28% in the last year.
Measured over the past years, BIM shows a quite strong growth in Revenue. The Revenue has been growing by 8.27% on average per year.
EPS 1Y (TTM)-8.23%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%

3.2 Future

BIM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.12% yearly.
BIM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.02% yearly.
EPS Next Y17.07%
EPS Next 2Y14.82%
EPS Next 3Y13.55%
EPS Next 5Y12.12%
Revenue Next Year5.84%
Revenue Next 2Y6.15%
Revenue Next 3Y6.3%
Revenue Next 5Y6.02%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.15 indicates a quite expensive valuation of BIM.
61.54% of the companies in the same industry are more expensive than BIM, based on the Price/Earnings ratio.
BIM's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.41.
Based on the Price/Forward Earnings ratio of 20.60, the valuation of BIM can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BIM is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.40, BIM is valued a bit cheaper.
Industry RankSector Rank
PE 27.15
Fwd PE 20.6
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

72.31% of the companies in the same industry are more expensive than BIM, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 67.69% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.23
EV/EBITDA 12.63
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BIM may justify a higher PE ratio.
BIM's earnings are expected to grow with 13.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.59
PEG (5Y)2.49
EPS Next 2Y14.82%
EPS Next 3Y13.55%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.82%, BIM is not a good candidate for dividend investing.
BIM's Dividend Yield is comparable with the industry average which is at 2.15.
With a Dividend Yield of 0.82, BIM pays less dividend than the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 0.82%

5.2 History

On average, the dividend of BIM grows each year by 19.40%, which is quite nice.
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

28.08% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.08%
EPS Next 2Y14.82%
EPS Next 3Y13.55%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (12/5/2025, 5:36:15 PM)

104.8

+0.6 (+0.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04
Earnings (Next)03-05 2026-03-05/amc
Inst Owners20.87%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap12.40B
Revenue(TTM)4.12B
Net Income(TTM)377.90M
Analysts72.94
Price Target126.31 (20.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.82%
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP28.08%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.36%
PT rev (3m)-0.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.04%
EPS NY rev (3m)-0.99%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-1.56%
Valuation
Industry RankSector Rank
PE 27.15
Fwd PE 20.6
P/S 3.01
P/FCF 28.23
P/OCF 15.75
P/B 3.15
P/tB 4.44
EV/EBITDA 12.63
EPS(TTM)3.86
EY3.68%
EPS(NY)5.09
Fwd EY4.86%
FCF(TTM)3.71
FCFY3.54%
OCF(TTM)6.66
OCFY6.35%
SpS34.82
BVpS33.24
TBVpS23.61
PEG (NY)1.59
PEG (5Y)2.49
Graham Number53.73
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROCE 11.69%
ROIC 8.55%
ROICexc 9.37%
ROICexgc 13.09%
OM 12.37%
PM (TTM) 9.17%
GM 56.27%
FCFM 10.66%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexgc growth 3Y-22.62%
ROICexgc growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Debt/EBITDA 0.36
Cap/Depr 73.33%
Cap/Sales 8.45%
Interest Coverage 250
Cash Conversion 79.99%
Profit Quality 116.27%
Current Ratio 2.27
Quick Ratio 1.3
Altman-Z 6.56
F-Score8
WACC7.91%
ROIC/WACC1.08
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.23%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
EPS Next Y17.07%
EPS Next 2Y14.82%
EPS Next 3Y13.55%
EPS Next 5Y12.12%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
Revenue Next Year5.84%
Revenue Next 2Y6.15%
Revenue Next 3Y6.3%
Revenue Next 5Y6.02%
EBIT growth 1Y-1.89%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year64.21%
EBIT Next 3Y26.04%
EBIT Next 5Y18.21%
FCF growth 1Y133.85%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y66.85%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%

BIOMERIEUX / BIM.PA FAQ

What is the ChartMill fundamental rating of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.


Can you provide the valuation status for BIOMERIEUX?

ChartMill assigns a valuation rating of 4 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.


How profitable is BIOMERIEUX (BIM.PA) stock?

BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for BIM stock?

The Price/Earnings (PE) ratio for BIOMERIEUX (BIM.PA) is 27.15 and the Price/Book (PB) ratio is 3.15.


Is the dividend of BIOMERIEUX sustainable?

The dividend rating of BIOMERIEUX (BIM.PA) is 3 / 10 and the dividend payout ratio is 28.08%.